Bayesian Capital Management, LP Procept Bio Robotics Corp Transaction History
Bayesian Capital Management, LP
- $788 Million
- Q4 2024
A detailed history of Bayesian Capital Management, LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bayesian Capital Management, LP holds 9,590 shares of PRCT stock, worth $648,379. This represents 0.1% of its overall portfolio holdings.
Number of Shares
9,590Holding current value
$648,379% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
294Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$348 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$236 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$118 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$101 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$81.6 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.01B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...